Loading…
Monday, June 16
 

11:00am EDT

#107: From Approval to Access: Integrating Patient Insights into Coverage Decisions
Monday June 16, 2025 11:00am - 12:00pm EDT
Component Type: Session
Level: Intermediate
CE: ACPE 1.00 Knowledge UAN: 0286-0000-25-513-L04-P; CME 1.00; RN 1.00

Despite advances, patient engagement (PE) in post-approval access decisions remains limited, complex, and unclear. This session examines how patients can offer value-based insights and explores pathways to strengthen PE in product access decisions.

Learning Objectives

Identify existing opportunities to incorporate patient input into access determinations; Recognize patient-contributed information and data that could broaden the evidentiary base for CMS and other payers; Discuss the resources and frameworks needed for CMS to systematically and scientifically engage with patient communities.

Chair

June Cha, PhD, MPH

Speaker

Vital Voices from Patients in Access Determination
June Cha, PhD, MPH

Patients Engaging with CMS: Opportunities, challenges, and lessons learned
Kristi Martin, MA, MPA

Patient Perspectives: Are They Missing from Commercial Payer Drug Coverage Policies?
James Chambers, PhD, MPharm, MSc

How Breakthrough T1D has Engaged CMS
Campbell Hutton, MPH


Speakers
avatar for June Cha

June Cha

Policy Director, FasterCures, Milken Institute, United States
June Cha is a policy director at FasterCures, Milken Institute Health. She brings decades of experience in infectious diseases research, non-profit, multilateral, and bilateral organizations, government, and the pharmaceutical industry, where she has focused on US and global health... Read More →
avatar for James Chambers

James Chambers

Professor, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, United States
James Chambers is a Professor at Tufts Medical Center’s Institute for Clinical Research and Health Policy Studies. His research focuses on insurance coverage of medical technology and the role of cost-effectiveness in U.S. health care.
avatar for Campbell Hutton

Campbell Hutton

Senior Vice President, Global Advocacy, Breakthrough T1D, United States
Campbell Hutton, is Senior Vice President, Global Advocacy at Breakthrough T1D, a non-profit organization whose mission is to accelerate life-changing breakthroughs to cure, prevent and treat type 1 diabetes (T1D) and its complications. In her role she oversees the regulatory affairs... Read More →
avatar for Kristi Martin

Kristi Martin

Director, Camber Collective, United States
Kristi Martin is a seasoned health policy expert with over 20 years of experience in the public sector, private sector, and philanthropy. She is currently a Director at Camber Collective, a strategy consulting firm known for its analytic rigor and human-centered approach. Kristi began... Read More →
Monday June 16, 2025 11:00am - 12:00pm EDT
202A Walter E. Washington Convention Center 801 Allen Y. Lew Place, NW Washington, DC 20001-3614 USA
  05: Patient-Impact-Product-Dev, Session

11:00am EDT

#112: Unintended Consequences: Effects of Inflation Reduction Act on the Future of Pharmaceutical Innovation
Monday June 16, 2025 11:00am - 12:00pm EDT
Component Type: Forum
Level: Intermediate
CE: ACPE 1.00 Knowledge UAN: 0286-0000-25-518-L04-P; CME 1.00; RN 1.00

Among the largest areas of concern with the Inflation Reduction Act (IRA) are potential unintended consequences to pharmaceutical innovation. This forum will convene industry experts to explore the impact of and potential adjustments to the IRA.

Learning Objectives

Discuss the unintended consequences of the IRA on innovation; Examine potential legislative solutions.

Chair

Sarah Martin, PhD, MS

Speaker

Panelist
Gregory Daniel, PhD, MPH

Industry Perspective
Ryan Gough

The Impacts of the Inflation Reduction Act on Biopharmaceutical Investment Decisions
Richard Xie, PhD

Early Signals of IRA Impact: Theoretical and Observed Unintended Consequences
Julie Ann Patterson, PharmD, PhD


Speakers
avatar for Gregory Daniel

Gregory Daniel

Vice President, Head of Public Policy Innovation and Evidence, Eli Lilly and Company, United States
Gregory Daniel, PhD, MPH, is the Global Head of Public Policy at Eli Lilly & Company in Washington, D.C. Greg is also on the board of directors for the Innovation in Value Initiative (IVI), adjunct associate professor at the UNC Eshelman School of Pharmacy, and Visiting Expert at... Read More →
RG

Ryan Gough

Partner, Senior Vice President, Public Affairs, Woodberry Associates and PACH, United States
avatar for Sarah Martin

Sarah Martin

Senior Director - Global Regulatory Policy (Oncology), Eli Lilly & Co., United States
Sarah currently serves as senior director of global regulatory policy for oncology at Lilly. She previously served as senior director of science and regulatory advocacy for the Pharmaceutical Research and Manufacturers of America (PhRMA) where she led their regulatory advocacy efforts... Read More →
avatar for Julie Patterson

Julie Patterson

Senior Director of Research, National Pharmaceutical Council, United States
Julie Patterson, PharmD, PhD, is Senior Director of Research and Director of the NPC Enterprise Lab at the National Pharmaceutical Council. She designs and conducts policy-relevant research related to sustainable access to innovative biopharmaceuticals, often focusing on incentives... Read More →
avatar for Richard Xie

Richard Xie

Senior Health Economist, RA Capital Management, United States
Richard Xie has over a decade of experience in conducting rigorous economic analyses to inform health policy issues. As a Senior Health Economist at RA Capital, he collaborates with diverse stakeholders to communicate the value of pharmaceutical innovation to payers, policymakers... Read More →
Monday June 16, 2025 11:00am - 12:00pm EDT
201 Walter E. Washington Convention Center 801 Allen Y. Lew Place, NW Washington, DC 20001-3614 USA
  09: Regulatory, Forum
  • Level Intermediate
  • Keyword Payers
  • Level Intermediate
  • format csv
  • Credit Type ACPE, CME, RN
  • Feature Topics Payers
  • Tags Forum
 
  • Filter By Date
    Jun 9 - 19, 2025
    June 2025
    SunMonTueWedThuFriSat
    1234567
    891011121314
    15161718192021
    22232425262728
    2930 
  • Filter By Venue
  • Filter By Type
  • Level
  • Keyword
  • Timezone

Share Modal

Share this link via

Or copy link

Filter sessions
Apply filters to sessions.